Our Mission

Our mission is to establish new equilibriums that solve complex diseases.

As a clinical-stage company focused on macrophage reprogramming, we intend to develop and commercialize a drug pipeline for macrophage reprogramming in solid cancers, Sepsis and other indications.

Our pioneering Allocetra™ cell-based therapy breaks with old paradigms, offering to effectively treat numerous acute conditions through a radically different clinical approach.

Advanced clinical-stage pipeline

Advanced clinical-stage pipeline

Short regulatory approval pathway

Short regulatory approval pathway
FDA & EU orphan designations; Specialized Life-Threatening Regulation in Europe potentially enables post-Phase II marketing approval

Take a look at our company overview

Download

Strong leadership,
inspired by great science and a sense of mission

Our management, clinical advisors, personnel, and affiliates have extensive knowledge
in the research and development of therapies based on macrophage reprogramming.

  • Shai Novik

    Executive Chairman

    Read More

    Oren Hershkovitz, Ph.D.

    Chief Executive Officer

    Read More

    Prof. Dror Mevorach, M.D.

    Chief Scientific Officer

    Read More

    Shachar Shlosberger

    CFO

    Read More

    Einat Galamidi

    VP Medical

    Read More

    Veronique Amor-Baroukh

    Senior Director of Operations

    Read More

    Iris Tavor

    Senior Director of RA/QA

    Read More

    Chen Ankri

    Director of Pre-Clinical & Clinical pharmacology

    Read More

    Sigal Arad

    Director of HR

    Read More
  • Shai Novik

    Executive Chairman

    Read More

    Dr. Roger Pomerantz

    Vice Chairman

    Read More

    Dr. Brian Schwartz, MD

    Director

    Read More

    Sangwoo Lee

    Director

    Read More

    Abraham Havron, Ph.D

    Director

    Read More

    Gili Hart, Ph.D

    Director

    Read More
  • Dr. Paul J. Martin, MD

    Fred Hutchinson Cancer Research Center, University of Washington

    Read More

    Dr. Mohamad Mohty, MD, PHD

    Saint-Antoine Hospital, Paris

    Read More

    Dr. James Ferrara, MD

    The Icahn School of Medicine at Mount Sinai

    Read More

    Dr. Mitchell Levy, MD, MCCM

    The Warren Alpert Medical School of Brown University

    Read More

    Dr. Clifford Deutschman, MD

    The Feinstein Institute for Medical Research

    Read More